P
CELG

Pitcairn’s Celgene Corp CELG Stock Holding History

Pitcairn’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,605
Closed -$457K – 585
2019
Q3 		$457K Sell
4,605
-70
-1% -$6.65K 0.05% 261
2019
Q2 		$432K Buy
4,675
+273
+6% +$25.9K 0.04% 277
2019
Q1 		$415K Buy
4,402
+113
+3% +$9.88K 0.05% 261
2018
Q4 		$275K Buy
4,289
+124
+3% +$9.15K 0.03% 332
2018
Q3 		$373K Sell
4,165
-297
-7% -$26.2K 0.04% 335
2018
Q2 		$354K Sell
4,462
-191
-4% -$15.9K 0.04% 345
2018
Q1 		$415K Sell
4,653
-130
-3% -$12.5K 0.04% 280
2017
Q4 		$499K Sell
4,783
-3,409
-42% -$385K 0.05% 265
2017
Q3 		$1.19M Buy
8,192
+3,606
+79% +$491K 0.14% 104
2017
Q2 		$595K Sell
4,586
-212
-4% -$26K 0.07% 203
2017
Q1 		$597K Sell
4,798
-170
-3% -$20.3K 0.07% 210
2016
Q4 		$575K Sell
4,968
-86
-2% -$9.58K 0.07% 212
2016
Q3 		$528K Buy
5,054
+106
+2% +$11.5K 0.07% 236
2016
Q2 		$488K Buy
4,948
+38
+0.8% +$3.93K 0.06% 231
2016
Q1 		$492K Buy
4,910
+121
+3% +$12.5K 0.06% 237
2015
Q4 		$573K Sell
4,789
-360
-7% -$41.6K 0.06% 214
2015
Q3 		$557K Buy
5,149
+601
+13% +$74.6K 0.07% 217
2015
Q2 		$526K Sell
4,548
-22
-0.5% -$2.52K 0.06% 240
2015
Q1 		$527K Sell
4,570
-247
-5% -$29.5K 0.06% 248
2014
Q4 		$538K Sell
4,817
-83
-2% -$8.75K 0.06% 229
2014
Q3 		$464K Buy
4,900
+2,426
+98% +$219K 0.05% 270
2014
Q2 		$212K Sell
2,474
-2,802
-53% -$213K 0.02% 435
2014
Q1 		$368K Sell
5,276
-20,656
-80% -$1.64M 0.04% 324
2013
Q4 		$2.19M Buy
25,932
+1,716
+7% +$136K 0.24% 72
2013
Q3 		$1.87M Buy
24,216
+872
+4% +$61.1K 0.23% 81
2013
Q2 		$1.36M Buy
+23,344
New +$1.4M 0.18% 116

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Pitcairn's CELG Position: Q4 2019 in Review

Pitcairn sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,605 shares — an estimated $457K sold.

Pitcairn first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.19M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pitcairn reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pitcairn sold 4,605 Celgene Corp shares in Q4 2019, an estimated $457K.
  • Pitcairn first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Pitcairn's Celgene Corp position peaked at $2.19M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pitcairn's 13F filing for Q4 2019, filed 12 Feb 2020.